Evidence map›Paper›PMID 36768000›Full record

ArticleInternational journal of environmental research and public health2023

Metabolic Control, Diabetic Complications and Drug Therapy in a Cohort of Patients with Type 1 and Type 2 Diabetes in Secondary and Tertiary Care between 2004 and 2019.

Matthias Roth, Thomas Lehmann, Christof Kloos, Sebastian Schmidt, Christiane Kellner, Gunter Wolf, Nicolle Müller

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthias RothDepartment of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0001-8682-3232
Thomas LehmannInstitute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, 07743 Jena, Germany.
Christof KloosDepartment of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany.
Sebastian SchmidtDepartment of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany.
Christiane KellnerDepartment of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany.
Gunter WolfDepartment of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0002-3291-0610
Nicolle MüllerDepartment of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0002-0303-7322

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper studies the features of metabolic parameters, diabetic complications and drug therapy of a single-centre cohort of patients with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) in secondary care and tertiary care over a 15-year period.

methodsRetrospective cross-sectional analysis of four single-centre cohorts between 2004 and 2019. All patients with T1DM or T2DM in secondary care (

resultsDiabetes duration increased in both patients with T1DM and T2DM in secondary care and tertiary care (

conclusionsThe increased prevalence of complications is likely due to older age and longer diabetes duration. Low rates of hypoglycaemia, lower limb amputations and good glycaemic control in secondary care patients indicate a good structure of patient care.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HypoglycemiaCross-Sectional StudiesHumansInsulinRetrospective StudiesTertiary Health CareInsulincomplicationsdiabetes mellitusmetabolic controlquality of caretherapy

Identifiers

PMID36768000
PMCPMC9916122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.